Gastrointestinal Stromal Tumors (GISTs) Treatment Market Report

Global and Region Gastrointestinal Stromal Tumors (GISTs) Treatment Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 03, 2022
  • PAGES：146
  • REPORT CODE：GMM1022046
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • A Gastrointestinal Stromal Tumor (GIST) is a type of tumor which occurs in the gastrointestinal tract and most commonly in the stomach or small intestine.

    The report details the trend, potential and market size of Gastrointestinal Stromal Tumors (GISTs) Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Gastrointestinal Stromal Tumors (GISTs) Treatmentmarket, defines the market attractiveness level of Gastrointestinal Stromal Tumors (GISTs) Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Gastrointestinal Stromal Tumors (GISTs) Treatment industry, describes the types of Gastrointestinal Stromal Tumors (GISTs) Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Gastrointestinal Stromal Tumors (GISTs) Treatment market and the development prospects and opportunities of Gastrointestinal Stromal Tumors (GISTs) Treatment industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Gastrointestinal Stromal Tumors (GISTs) Treatment market in Chapter 13.

    By Player:

    • Novartis

    • Roche

    • Sun Pharmaceutical

    • Arog Pharmaceuticals

    • Immunicum

    • Bayer

    • Pfizer

    • Boston Biomedical

    • AB Science

    • Natco Pharma

    By Type:

    • Surgery

    • Targeted Therapy

    • Radiation Therapy

    • Chemotherapy

    • Ablation

    • Embolization

    • Others

    By End-User:

    • Hospitals

    • Clinics

    • Ambulatory Surgical Centers

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Gastrointestinal Stromal Tumors (GISTs) Treatment Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Gastrointestinal Stromal Tumors (GISTs) Treatment Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Gastrointestinal Stromal Tumors (GISTs) Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Gastrointestinal Stromal Tumors (GISTs) Treatment Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Gastrointestinal Stromal Tumors (GISTs) Treatment Market Analysis and Outlook to 2022

    • 7.1 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption (2017-2022)

    • 7.2 United States Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption (2017-2022)

    • 7.3 Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption (2017-2022)

    • 7.4 China Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption (2017-2022)

    • 7.5 Japan Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption (2017-2022)

    • 7.6 India Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption (2017-2022)

    • 7.7 South Korea Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption (2017-2022)

    8 Region and Country-wise Gastrointestinal Stromal Tumors (GISTs) Treatment Market Analysis and Outlook to 2028

    • 8.1 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Forecast (2022-2028)

    • 8.2 United States Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Forecast (2022-2028)

    • 8.3 Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Forecast (2022-2028)

    • 8.4 China Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Forecast (2022-2028)

    • 8.5 Japan Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Forecast (2022-2028)

    • 8.6 India Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Forecast (2022-2028)

    • 8.7 South Korea Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Forecast (2022-2028)

    9 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Outlook by Types and Applications to 2022

    • 9.1 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Surgery Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Targeted Therapy Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Radiation Therapy Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Chemotherapy Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Ablation Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Embolization Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Outlook by Types and Applications to 2028

    • 10.1 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Surgery Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Radiation Therapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Ablation Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Embolization Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.7 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Gastrointestinal Stromal Tumors (GISTs) Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Competitive Analysis

    • 14.1 Novartis

      • 14.1.1 Novartis Company Details

      • 14.1.2 Novartis Gastrointestinal Stromal Tumors (GISTs) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Novartis Gastrointestinal Stromal Tumors (GISTs) Treatment Product and Service

    • 14.2 Roche

      • 14.2.1 Roche Company Details

      • 14.2.2 Roche Gastrointestinal Stromal Tumors (GISTs) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Roche Gastrointestinal Stromal Tumors (GISTs) Treatment Product and Service

    • 14.3 Sun Pharmaceutical

      • 14.3.1 Sun Pharmaceutical Company Details

      • 14.3.2 Sun Pharmaceutical Gastrointestinal Stromal Tumors (GISTs) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Sun Pharmaceutical Gastrointestinal Stromal Tumors (GISTs) Treatment Product and Service

    • 14.4 Arog Pharmaceuticals

      • 14.4.1 Arog Pharmaceuticals Company Details

      • 14.4.2 Arog Pharmaceuticals Gastrointestinal Stromal Tumors (GISTs) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Arog Pharmaceuticals Gastrointestinal Stromal Tumors (GISTs) Treatment Product and Service

    • 14.5 Immunicum

      • 14.5.1 Immunicum Company Details

      • 14.5.2 Immunicum Gastrointestinal Stromal Tumors (GISTs) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Immunicum Gastrointestinal Stromal Tumors (GISTs) Treatment Product and Service

    • 14.6 Bayer

      • 14.6.1 Bayer Company Details

      • 14.6.2 Bayer Gastrointestinal Stromal Tumors (GISTs) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Bayer Gastrointestinal Stromal Tumors (GISTs) Treatment Product and Service

    • 14.7 Pfizer

      • 14.7.1 Pfizer Company Details

      • 14.7.2 Pfizer Gastrointestinal Stromal Tumors (GISTs) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Pfizer Gastrointestinal Stromal Tumors (GISTs) Treatment Product and Service

    • 14.8 Boston Biomedical

      • 14.8.1 Boston Biomedical Company Details

      • 14.8.2 Boston Biomedical Gastrointestinal Stromal Tumors (GISTs) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Boston Biomedical Gastrointestinal Stromal Tumors (GISTs) Treatment Product and Service

    • 14.9 AB Science

      • 14.9.1 AB Science Company Details

      • 14.9.2 AB Science Gastrointestinal Stromal Tumors (GISTs) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 AB Science Gastrointestinal Stromal Tumors (GISTs) Treatment Product and Service

    • 14.10 Natco Pharma

      • 14.10.1 Natco Pharma Company Details

      • 14.10.2 Natco Pharma Gastrointestinal Stromal Tumors (GISTs) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Natco Pharma Gastrointestinal Stromal Tumors (GISTs) Treatment Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Gastrointestinal Stromal Tumors (GISTs) Treatment

    • Figure Gastrointestinal Stromal Tumors (GISTs) Treatment Picture

    • Table Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption by Country (2017-2022)

    • Figure United States Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption and Growth Rate (2017-2022)

    • Table Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption and Growth Rate (2017-2022)

    • Figure China Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Japan Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption and Growth Rate (2017-2022)

    • Figure India Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Korea Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Forecast by Country (2022-2028)

    • Figure United States Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Surgery Consumption and Growth Rate (2017-2022)

    • Figure Global Targeted Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Radiation Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Chemotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Ablation Consumption and Growth Rate (2017-2022)

    • Figure Global Embolization Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Surgery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Radiation Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ablation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Embolization Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Gastrointestinal Stromal Tumors (GISTs) Treatment Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Gastrointestinal Stromal Tumors (GISTs) Treatment Export by Region (Top 5 Countries) (2017-2028)

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Gastrointestinal Stromal Tumors (GISTs) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Gastrointestinal Stromal Tumors (GISTs) Treatment Product and Service

    • Table Roche (Foundation Year, Company Profile and etc.)

    • Table Roche Gastrointestinal Stromal Tumors (GISTs) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Gastrointestinal Stromal Tumors (GISTs) Treatment Product and Service

    • Table Sun Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Sun Pharmaceutical Gastrointestinal Stromal Tumors (GISTs) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sun Pharmaceutical Gastrointestinal Stromal Tumors (GISTs) Treatment Product and Service

    • Table Arog Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Arog Pharmaceuticals Gastrointestinal Stromal Tumors (GISTs) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Arog Pharmaceuticals Gastrointestinal Stromal Tumors (GISTs) Treatment Product and Service

    • Table Immunicum (Foundation Year, Company Profile and etc.)

    • Table Immunicum Gastrointestinal Stromal Tumors (GISTs) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Immunicum Gastrointestinal Stromal Tumors (GISTs) Treatment Product and Service

    • Table Bayer (Foundation Year, Company Profile and etc.)

    • Table Bayer Gastrointestinal Stromal Tumors (GISTs) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Gastrointestinal Stromal Tumors (GISTs) Treatment Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Gastrointestinal Stromal Tumors (GISTs) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Gastrointestinal Stromal Tumors (GISTs) Treatment Product and Service

    • Table Boston Biomedical (Foundation Year, Company Profile and etc.)

    • Table Boston Biomedical Gastrointestinal Stromal Tumors (GISTs) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boston Biomedical Gastrointestinal Stromal Tumors (GISTs) Treatment Product and Service

    • Table AB Science (Foundation Year, Company Profile and etc.)

    • Table AB Science Gastrointestinal Stromal Tumors (GISTs) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table AB Science Gastrointestinal Stromal Tumors (GISTs) Treatment Product and Service

    • Table Natco Pharma (Foundation Year, Company Profile and etc.)

    • Table Natco Pharma Gastrointestinal Stromal Tumors (GISTs) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Natco Pharma Gastrointestinal Stromal Tumors (GISTs) Treatment Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US